Navigation Links
Health Briefs TV Features SFJ Pharmaceuticals
Date:9/20/2013

Coral Springs, FL (PRWEB) September 20, 2013

The producers of Health Briefs TV are pleased to announce that SFJ Pharmaceuticals will be featured in an upcoming segment on "Innovative Drug Development and Clinical Research Driving Improved Patient Care" as part of the show's Medical Minutes series.

Their value of pharmaceuticals is especially evident in the field of oncology, where the speed of development and availability of drugs may offer the first ever treatment, or have significant advantages over existing drugs. With the costs of developing a cancer drug reaching up to one billion dollars, however, many pharmaceutical companies are using a step-by-step approach. They first advance their most promising drugs for one cancer type, line of therapy or stage, and then advance for additional cancer types, lines of therapy or stages, thus delaying the time it takes for life-saving and life-enhancing to get into the hands or physicians and patients.

Additionally, drugs are first developed for the largest markets, like breast and lung cancer. Drugs for other cancer types, like thyroid and kidney, are not as aggressively developed. Years may go by while patients in need wait, without access to life-saving or life-enhancing drugs.

Pleasanton, California-headquartered SFJ Pharmaceuticals has developed a revolutionary model to overcome drug development challenges. The company captures the lost value for pharmaceutical companies and patients, by taking drugs which are proven in one type of cancer, and helping to accelerate them through clinical development for many different types and stages of cancer.

The five-minute Health Briefs TV segment will educate viewers on the importance of efficient drug development, and will feature the innovative model developed by SFJ Pharmaceuticals to make drugs available to more patients, sooner. The segment will highlight several of SFJ's partnerships, including Eisai Pharmaceuticals for Phase III development of their drug, Lenvatinib, to treat 131I-Refractory Differentiated Thyroid Cancer; Pfizer's drug, Dacomitinib, for first-line treatment of non-small cell lung cancer; and Pfizer's drug, Axitinib, for the adjuvant treatment of renal cell carcinoma. For more information about SFJ Pharmaceuticals, please visit http://www.sfj-pharma.com.

Read the full story at http://www.prweb.com/releases/health-briefs-tv-and-sfj/pharmaceuticals-seg/prweb11138064.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bel Marra Health Reports on Recent Research Finding Prolonged Life in Those Who Receive Corrective Eye Surgery
2. Online USA Doctors/Virtual Doctors Creates Comprehensive Female Health Plan That Prevents Premature Death in Postmenopausal Women
3. Diet Doc Hormone Diets & Weight Loss Plans Now Helps Clients Achieve a Healthy Lifestyle and Eliminate Causes of Weight Gain With Exclusive Diet Pills
4. Gorman Health Group Expert to Outline the Components of a Successful Medicare Advantage Risk-Adjustment Program
5. Zion Health Announces Native Remedy; Ancient Clay Soaps for Sensitive Skin; New Addition to Whole Foods Market Body Care in Andover, MA
6. Best Natural Acne Treatment Review Published by Health Company
7. School of Public Health Receives $390,000 Grant to Study Alcohol Use Among Youth Acquiring HIV
8. CHL to Hold Original Thought-Leadership Series about Need for Hispanics in the Healthcare and Biomedical Fields; City of Hope to Host Signature Event on Their Campus
9. CDPHP Health Plans Ranked As Best in New York State
10. Oakwood Medical Avatar Brings Personalized Health Info to Mobile Devices
11. Online USA Doctors Announces a New Online, Medical Record System That Improves Patient Health Outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... , ... February 26, 2017 , ... ... 2011 the lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited ... allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard that sets out ...
(Date:2/26/2017)... York (PRWEB) , ... February 26, 2017 , ... ... products for wholesale distribution in North America, today announced it would be offering ... The company, which prides itself on crafting quality and unique baby clothing/feeding products, ...
(Date:2/26/2017)... Park, KS (PRWEB) , ... ... ... of StaffBridge sets a new technology standard in staffing, scheduling, and reporting ... manage, monitor, and predict activity throughout the entire staffing process. StaffBridge technology ...
(Date:2/26/2017)... (PRWEB) , ... February 26, 2017 , ... ... patients after receiving cognitive rehabilitation, according to a study released today at the ... that cognitive rehabilitation programs are proven to be effective in improving cognitive function ...
(Date:2/25/2017)... ... February 25, 2017 , ... FCPX users now have the ... Pixel Film Studios. With ProSharpen Color users have total control over sharpening amount, sharpening ... color range. With color spectrum tools users can visually see the color range effected ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... -- Leading Countries, Technologies and Companies ... at a CAGR of 8.9% from 2016-2021 and CAGR of 9.2% ... of 9.1% from 2016 to 2027. The market is estimated at ... ... Read on to discover how you can exploit the future business ...
(Date:2/27/2017)... Feb 27, 2017 The Dutch ... NATO for use at the security level RESTRICTED. The solution ... NATO organization for the communication of classified information. ... Sectra and Samsung ... an eavesdrop-secure smartphone solution. Sectra Tiger/R is developed by Sectra ...
(Date:2/24/2017)... Feb. 24, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the Cowen and Company 37 ... Marriott Copley Place on Tuesday, March 7, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
Breaking Medicine Technology: